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Abstract CD95 and ceramide are known to be involved in the apoptotic mechanism. The triggering of CD95
induces a cascade of metabolic events that progressively and dramatically modifies the cell shape by intense membrane
blebbing, leading to apoptotic bodies production. Although the CD95 pathway has been abundantly described in
normal thyrocytes, the effects of cell permeable synthetic ceramide at morphological and biochemical levels are not
fully known. In the present study, we show that thyroid follicular cells (TFC) exposed to 20 mMof C2-ceramide for 4 h are
characterized by morphological features of necrosis, such as electron-lucent cytoplasm, mitochondrial swelling, and
loss of plasma membrane integrity without drastic morphological changes in the nuclei. By contrast, TFC treated with
2 mM of C2-ceramide for 4 h are able to accumulate GD3, activate caspases cascade, and induce apoptosis.
Furthermore, we provide evidence that 20 mM of C2-ceramide determine the destruction of mitochondria and are not
able to induce PARP cleavage and internucleosomal DNA fragmentation, suggesting that the apoptotic program is not
activated during the death process and nuclear DNA is randomly cleaved as the consequence of cellular degeneration.
Pretreatment with 30 mM of zVAD-fmk rescued TFC from 2 mM of C2-ceramide-induced apoptosis, whereas, 20 mM of
C2-ceramide exposure induced necrotic features. Dcm was obviously altered in cells treated with 20 mM of C2-ceramide
for 4 h (75% 3.5%) compared with the low percentage (12.5% 0.4%) of cells with altered Dcm exposed to 2 mM of
C2-ceramide. Whereas, only 20% 1.1% of cells treated with anti-CD95 for 1 h showed altered Dcm. Additionally, Bax
and Bak, two pro-apoptotic members, seem to be not oligomerized in the mitochondrial membrane following ceramide
exposure. These results imply that high levels of exogenous ceramide contribute to the necrotic process in TFC, and may
provide key molecular basis to the understanding of thyroid signaling pathways that might promote the apoptotic
mechanism in thyroid tumoral cells. J. Cell. Biochem. 86: 162–173, 2002.  2002 Wiley-Liss, Inc.
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Apoptosis is a peculiar form of genetically-
regulated cell death that plays a crucial role in
the development and homeostasis of multi-
cellular organisms [Cohen, 1993]. The morpho-
logical and biochemical changes of apoptosis are
accompanied by cytoplasmic blebbing, chroma-
tin condensation, DNA fragmentation, and
membrane budding, culminating in compact
packaging of the cellular debris into apoptotic
bodies.
Apoptosis induced by CD95 is involved in
various aspects of mammalian development
and especially in thehomeostasis of the immune
system [Miller and J, 1998; De Maria et al.,
1999; Song andSteller, 1999]. CD95 is one of the
best characterized death surface receptors
belonging to the tumor necrosis factor (TNF)
receptor gene superfamily [Nagata, 1997]. The
interactions between death receptors and their
ligands play a pivotal role in controlling the
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apoptosis mechanism in physiological and
pathological processes, such as autoimmune
diseases [Stassi et al., 1997, 1999a,b, 2000; De
Maria and Testi, 1998]. Recruitment of cas-
pases, a family of cysteine proteases, induces
proteolytic cleavage ofmultiple cellular targets,
consequently determining specific changes in
cell surface and nuclear morphology [Salvesen
and Dixit, 1997; Thornberry et al., 1997].
During the apoptotic process, surface morpho-
logical changes have demonstrated discrete
stages of cell rounding, surface blebbing, sur-
face microspikes, followed by apoptotic bodies
formation [Collins et al., 1997].
The triggering of CD95 receptor results in
another cascade of metabolic events, thus
involving the activation of a sphingomyelinase
(SMase), which hydrolyses sphingomyelin (SM)
to ceramide [Cifone et al., 1994; Jarvis et al.,
1994; Testi, 1996; De Maria et al., 1997]. SM
hydrolysis is elicited not only by molecular
crosslinking of CD95 or TNF receptor, but also
by other apoptotic stimuli such as UV and g
irradiation [Ballou et al., 1996]. Ceramide
accumulation has been claimed as a major
mediator of CD95 induced apoptosis [Cifone
et al., 1994; Pushkareva et al., 1995; Tepper
et al., 1997]. Moreover, recent studies showed
that during this process ceramide enters the
synthetic pathway and is ultimately converted
to GD3 by the action of GD3 synthase, even in
infiltrating T lymphocytes in proximity to
CD178 producing thyroid follicules during
Hashimoto’s thyroiditis [De Maria et al., 1997;
Stassi et al., 1999a]. According to published
data, mitochondria are the immediate down-
stream target of GD3 [Rippo et al., 2000].
Accumulation of GD3 determines the loss of
mitochondrial membrane potential (Dcm) and
the release of cytochrome c that binds Apaf-1
and promotes the recruitment of pro-caspase-9,
forming a complex called ‘‘apoptosome,’’ an
apoptogenic structure that cleaves and acti-
vates pro-caspase-3 and other executor cas-
pases [Kroemer et al., 1997; Green and
Kroemer, 1998; Hengartner, 2000]. Subse-
quently, this caspase cascade generates irre-
versible apoptotic events, such as chromatin
condensation, activation of endonucleases and
DNA fragmentation. Dcm is the fundamental
parameter for the evaluation of mitochondrial
functionality and energy status of cells [Majno
and Joris, 1995;Mancini et al., 1997;Miller and
J, 1998]. The disruption of Dcm is considered
one of the early events of apoptosis, but accord-
ing to other points of view, the maintenance of
Dcm with ATP synthesis is crucial for a variety
of intracellular processes, including apoptosis
[Mancini et al., 1997; Nagata, 1997; Salvesen
and Dixit, 1997]. Apoptosis can be initiated by
several stimulations in different cell types, and
the kinetics of themetabolic events varywidely,
from only a few minutes to several days de-
pending on the cell system examined. In con-
trast, necrosis is a type of cell death resulting in
an early lysis of plasma membrane before any
significant nuclear morphological changes
[Majno and Joris, 1995]. Although the hallmark
features of CD95-induced apoptosis are amply
characterized in thyroid follicular cells (TFC),
morphological and biochemical events in cell
permeable synthetic ceramide-induced cell
death are largely unknown. Since downstream
signals activated by exogenous ceramide may
constitute part of the apoptotic pathway gener-
ated by CD95, we compared the morphological
and biochemical differences betweenCD95- and
ceramide-induced cell death.
MATERIALS AND METHODS
TFC Purification and Culture
Normal thyroid specimens were obtained at
the time of thyroidectomy from the uninvolved,
controlateral lobes of thyroids with tumors.
Thyroid tissues were digested for 2 h with
collagenase (1.5 mg/ml) (GIBCO-BRL, Grand
Island, NY) and hyaluronidase (20 mg/ml)
(Sigma Chemical Co., St. Louis, MO) in DMEM
[Stassi et al., 2000]. TFC were maintained in
culture with DMEM supplemented with 10%
fetal bovine serum (Euroclone, Victoria Street,
Paignton, Devon TQ4 5DN, UK). Anti-CD95
mAb (200 ng/ml; CH-11,IgM; Upstate Biotech-
nology, Lake Placid, NY), C2-ceramide and C2-
dihydroceramide (1–40 mM; Biomol Research
Laboratories, Inc., Plymouth Meeting, PA)
were added to suspension cells cultured in
polypropylene tubes at time, 0 and then cells
were harvested at 0, 1, 2, 3, and 4 h for the
surface, cytoplasmic, and nuclear morphologi-
cal changes, GD3 localization, mitochondrial
functionality, and the analysis of apoptotic
factors. For caspase inhibition, cells were pre-
treated for 30 min with protease inhibitors
(zVAD-FMK). Inhibitors were kept as stock
solutions of 20mM inDMSOand added directly
to cell cultures at 30 mM final concentration.
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Transmission Electron Microscopy
(TEM) and Scanning Electron
Microscopy (SEM)
For TEM cultured TFC, untreated and trea-
ted with anti-CD95 mAb, C2-ceramide and C2-
dihydroceramide, were centrifuged, washed
twice in 0.1M phosphate-buffered saline (PBS),
and immediately resuspended in 2.5% glutar-
aldehyde inPBS for 30min. Then, the cells were
post-fixed in 1% osmium tetraoxide (OsO4) for
30 min and rinsed twice in PBS. Successively,
the cells were dehydrated and embedded in
epoxy resin (Epon 812; Fluka Chemie AG,
Switzerland). Polymerization was carried out
at 608C for 48 h. Thin sections were mounted
onto nickel grids, stained with uranyl acetate
and lead citrate for 1–2min.TFCwere analyzed
by a Jeol 1220 electron microscope.
For SEM, following post-fixation with 1%
OsO4, the cells were progressive acetone dehy-
drated and critical point-dried with Emscope
CPD 750. After mounting on conductive carbon
adhesive tabs, the specimens were gold-palla-
dium coated by a Polaron LTD E5200. Observa-
tions were performed by a Jeol 6301 F scanning
electron microscope at 4–10 kV.
Annexin-V Staining
TFC exposed to anti-CD95 and C2-ceramide
were washed with PBS and labeling of phos-
phatidylserine (PS) was assessed using an
annexin-V staining kit (annexin-V-fluos stain-
ing kit; Boehringer Mannheim, Indianapolis,
IN).Then,TFCwereanalyzed byflowcytometer
(FACScan, Becton Dickinson, Mountain View,
CA).
Immunostaining Procedure
TFC treated with anti-CD95 (200 ng/ml) and
C2-ceramide (2–20 mM) for 4 h were harvested
and cytocentrifuged. Then, cells were allowed to
equilibrate at room temperature, and before
starting, the staining was exposed to absolute
acetone for 10 min. GD3 expression (anti-GD3;
S2-566, mouse IgM; Seikagaku, Tokyo, Japan)
or isotype matched control at appropriate
dilutions were detected following manufac-
turer’s instructions (Dako LSAB kit; Dako
Corporation, Santa Barbara, CA). The binding
was revealed by a AEC colorimetric substrate.
Hematoxylin aqueous formula was used as a
counterstain.
Dcm
TFC (3 105) treated with anti-CD95 mAb,
C2-ceramide andC2-dihydroceramidewere har-
vested,washed, and resuspended in 1ml of com-
pletemedium. Then, the cells were stainedwith
2.5 mg/ml JC-1 (5,50,6,60-tetrachloro-1,10,3,30-
tetra-ethylbenzimidazolylcarbocyanine iodide,
T-3168; Molecular Probes, Inc. Eugene, OR)
(32–34). After the dye was well dissolved, sam-
ples were kept in the dark at RT for 15 min.
Successively, the cells were washed twice
in PBS by centrifuging at 500g for 5 min,
and resuspended in PBS. Analysis was per-
formed by a flow cytometer (FACScan Becton
Dickinson).
Western Blotting
Cell pellets were resuspended in ice-cold NP-
40 lysis buffer (50mMTris-HCl, pH7.5, 150mM
NaCl, 1mMEGTA, 1%NP-40) containing 1mM
PMSF, leupeptin (1 mg/ml), pepstatin (1 mg/ml),
and aprotinin (1 mg/ml). After 30 min on ice, the
resulting lysates were centrifuged at 10,000g
for 10min to removenuclei and cell debris. Each
lysate (30 mg) was fractioned on 10% or 12%
sodium dodecyl sulfate–polyacrylamide gels
and blotted to nitrocellulose (Hybond, Amer-
sham, Little Chalfont Buckinghamshire Eng-
land, UK). Bound anti-Bcl-xL (H-5,mouse IgG1,
Santa Cruz Biotechnology), anti-Bcl-2 (124,
mouse IgG1, Upstate Biotechnology), anti-Bax
(rabbit polyclonal IgG, Upstate Biotechnology),
and anti-Bak (rabbit polyclonal IgG, Upstate
Biotechnology) were detected by HRP-conju-
gated anti-mouse or anti rabbit Abs (Amer-
sham) and visualized by an enhanced
chemiluminescence detection (ECL) system
(Super Signal West Dura Extended Duration




TFC pellets were homogenized with a glass–
Teflon directly into an ice-cold isolation buffer,
containing 5 mM Tris-HCl, pH 7.4, 0.25 mM
sucrose, 50 mg/ml soybean trypsin inhibitor,
1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml
pepstatin, and 1 mM PMSF. After centrifuga-
tion, the supernatants were collected into
fresh tubes and centrifuged at 25,000g for
10 min, at 48C. Equivalent amounts of proteins
lysated frommitochondrial pellets and cytosolic
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fractions were run in a 12% sodium dodecyl
sulfate–polyacrylamide gel and transferred to
nitrocellulose. Cytochrome cwas detected using
a monoclonal antibody (clone 7h8.2C12, Phar-




Untreated cells and those treated for 4 h with
200 ng/ml anti-CD95 and 2–20 mM of both C2-
ceramide and C2-dihydroceramide were rinsed
in PBS, collected by centrifugation, suspended,
and sonicated on ice in a buffer containing
50 mM glucose, 25 mM Tris-HCl, pH 8, 10 mM
EDTA, 1 mg/ml aprotinin, 1 mg/ml leupeptin,
1 mg/ml pepstatin, 10 mM sodium fluoride,
10 mM sodium ortovanadate, and 1 mM PMSF
at a concentration of 106 cells/20 ml. Following
the addition of a solution containing 50 mM
Tris-HCl, pH 6.8, 6Murea, 6% b-mercaptoetha-
nol, 3% SDS, and 0.003% bromophenol blue,
cell lysates were heated for 15 min at 658C.
Equivalent amounts of protein (30 mg) were
resolved on 10% SDS–PAGE, transferred
to nitrocellulose (Hybond, Amersham), and
probed with 1:1,000 anti-PARP mAb (C2-10,
IgG1; PharMingen). Blot visualization was
performed using ECL (Pierce).
Analysis of DNA Fragmentation
Untreated cells and those treated for 4 h with
anti-CD95, C2-ceramide, and C2-dihydrocera-
mide were lysed in a buffer containing 0.5%
SDS, 5 mM EDTA, 0.2% Triton X-100. Follow-
ing 5 min incubation, lysates were extracted
with phenol/chloroform and DNA was precipi-
tated with 3 M sodium acetate, pH 5.2 in cold
absolute ethanol for 20 min in dry ice. The dry
DNA pellet was dissolved in TE (50 mM Tris,
1 mM EDTA, pH 8) and incubated with RNase
for 45 min at 378C before re-extraction and
precipitation, as above. Then, DNA was dis-
solved in TE, quantified by spectrophotometry
at 260 nm and run in 1.8% agarose gel with 1 kb
DNA standard (GeneRulerTM, MBI Fermentas,
Vilnius, Lithuania).
Statistical Analysis
Results are shown as meanSEM. We
compared data on the basis of morphological
and functional parameters using an imaging
analyzer (Image Pro-Plus). All samples were
analyzed in blind fashion.
RESULTS
Dose-Dependent Effect of Cell-Permeable
Synthetic C2-Ceramide
Cell-permeable synthetic C2-ceramide treat-
ment and extracellular addition of SMase led to
the induction of cell death with DNA fragmen-
tation and apoptotic morphology [Cifone et al.,
1994; Jarvis et al., 1994].
These results prompted us to test a dose-
dependent response of TFC exposed to C2-
ceramide (1–40 mM) to evaluate whether
exogenous ceramide can induce a morphologi-
cally different kind of cell death (apoptosis or
necrosis). Annexin-V assay of TFC treated with
2 mM C2-ceramide for 4 h showed about 60% of
apoptotic cell death, whereas TFC treated with
20 and 40 mM C2-ceramide, showed about 70%
and 90% of necrotic cell death, respectively
(Fig. 1A).
To compare the induction of cell deathby anti-
CD95 and C2-ceramide, TFC were treated in
kinetics experiments (0–4 h) with different
doses of C2-ceramide (2–20 mM) and with
200 ng/ml of anti CD95 (CH-11) and succes-
sively stained with Annexin-V fluos and ana-
lyzed by cytofluorimeter and fluorescence
microscopy. At 1 h, approximately 12% of TFC,
treatedwithanti-CD95andC2-ceramide (2mM),
presented typically apoptotic features. This
population grew to approximately 85% and
70%, respectively at 4 h (Fig. 1B), whereas
TFC treated with C2-ceramide (20 mM) did not
present typically apoptotic features achieving a
peak of 20% at 4 h.
When we evaluated the typically necrotic
features, the predominant population was TFC
treated with C2-ceramide (20 mM). In fact, at
different time points, this population grew up to
85% at 4 h, while cells treated with anti-CD95
and C2-ceramide (2 mM) were little represented
(Fig. 1B).
Furthermore, fluorescence microscopy detec-
tion of cell-surface PS with annexin-V showed a
strong positivity on the surface of TFC treated
with anti-CD95 at all time points analyzed.
Arrowheads indicate apoptotic cells with bright
green staining and characteristic condensed
and fragmented nuclei (Fig. 1C, left panel). In
contrast, cells cultured in the presence of 20 mM
C2-ceramide for 4 h were mostly stained with
propidium iodide (PI) (red color), showing
cellular destruction with typically necrotic
features, and a negligible number of them
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stained in green, can be regarded as apoptotic
cells (Fig. 1C, right panel).
CD95 Stimulation and Ceramide Exposure
at Ultrastructural Levels
To determine whether CD95 is functional in
TFC, and therefore able to induce a death
signal, we incubated the cells with an agonist
anti-CD95mAb and examined themat different
time points for evidence of apoptosis. At 2 h of
incubation, we found 30% of cells at an early
apoptosis morphological stage, as evidenced by
the margination of chromatin, rounding of cells
together with the onset of cell surface blebbing
(Figs. 2 and 3). Several cells demonstrated
chromatin capping as well as its segregation
intodarkand lucent areas (not shown).Whenwe
analyzed 4 h cultures treated with anti-CD95,
Fig. 1. Response evaluation by annexin-V staining of TFC to
ceramide exposure. A: Apoptosis and necrosis evaluation on
TFC exposed to various doses of C2-ceramide. B: Kinetic
evaluation of apoptosis and necrosis on TFC exposed to anti-
CD95 (200 ng/ml) or C2-ceramide (2 and 20 mM). C: Left panel:
Cells exposed to anti-CD95 for 2 h. Arrowheads indicate
apoptotic cells with bright green staining and characteristic
condensed nuclei. Right panel: Cells treated with 20 mM C2-
ceramide for 2 h. Arrowheads show necrotic cells stained with
PI (red color) and advanced cellular destruction. [Color figure
can be viewed in the online issue, which is available at
www.interscience.wiley.com.]
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85% of cells were at late stages of apoptosis, as
shown by the formation of multiple apoptotic
bodies and echinoid spikes (Figs. 2 and 3). Chro-
matin in several apoptotic bodieswas enclosed in
morphologically intact nuclear membranes and
cytoplasm was electron-dense (Fig. 2).
In contrast, TFC exposed to C2-ceramide
(20 mM) for 2 h showed cell swelling, formation
of surface blisters separated by deep and ir-
regular furrows, and initial membrane lysis
(Figs. 2 and3).Wealso founda lowpercentage of
apoptotic events ranging from 4 to 10% after
exposure for various times to ceramide (data
not shown). In addition, about 80% of TFC
treated for 4 h with C2-ceramide (20 mM), were
typified by membrane lysis, mitochondrial
swelling, and dispersal of cytoplasmic orga-
nelles (Fig. 2). In particular, Figure 3 at 4 h
revealed the presence of several ruffles and
membrane breaking. The main feature of this
process, however, was the apparent integrity of
nuclear membrane (Fig. 2).
GD3 Accumulation and Dcm Evaluation
GD3 ganglioside accumulation is one of
the metabolic components involved in CD95-
induced apoptosis, responsible for engendering
an irreversible apoptotic signal [DeMaria et al.,
1997]. Since GD3 accumulation is able to
directly interact with mitochondria [Rippo
et al., 2000], we contemporarily studied GD3
accumulation and mitochondrial ultrastruc-
tural changes of TFC after 4 h of treatment
with anti-CD95 and C2-ceramide (2–20 mM).
Immunocytochemistry demonstrated strong
positivity for GD3 when TFC were exposed to
anti-CD95 and C2-ceramide (20 mM) (Fig. 4A),
while a lower accumulation of GD3 was repre-
sented in cells treatedwith2mMofC2-ceramide.
Moreover, the same cells treated with anti-
CD95, when analyzed by TEM, showed hyper-
activemitochondria, whilemitochondria of cells
cultured with C2-ceramide (2 mM) appeared
Fig. 2. TEM analysis following anti-CD95 and C2-ceramide
exposure. Upper Panels: Untreated TFC (6,000 and 5,000
respectively). Middle panels: TFC treated with anti-CD95 for 2 h,
characterized by peripheral chromatin margination (5,000) and
TFC exposed to 20 mM C2-ceramide for 2 h showing the initial
cell swelling with membrane lysis, surface blisters, and disruption
of cytoplasmic organelles (8,000). Lower panels: TFC treated
with anti-CD95 for 4 h demonstrating the apoptotic bodies
formation (5,000), and TFC exposed to 20 mM C2-ceramide for
4 h characterized by cytoplasmic disintegration (8,000).
Fig. 3. SEM of TFC treated with anti-CD95 and C2-ceramide.
Upper panels: Untreated cells (3,500 and 4,500, respec-
tively). Middle panels: Cells treated with anti-CD95 for 2 h,
characterized by intense membrane blebbing formation
(3,500) and cells exposed to 20 mM C2-ceramide for 2 h with
the presence of surface blisters (5,000). Lower panels:
Apoptotic bodies formation and echinoid spikes in CD95
treated cells for 4 h (3,500), and membrane disruption in
C2-ceramide treated cells for 4 h (5,000).
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condensed according to data that condensed
mitochondria have been observed in association
with apoptosis [Mancini et al., 1997; Zhuang
and Cohen, 1998]. Unexpectedly, 20 mM C2-
ceramide determined mitochondrial destruc-
tion (Fig. 4A).
Analyzing the mitochondrial activity of cells
with a specific probe JC-1, we found variations
in Dcm from the single cell to different concen-
trations of ceramide and anti-CD95. Particu-
larly, 75 3.5% of TFC treated with 20 mM
ceramide for 4 h showed disruption of Dcm,
Fig. 4. GD3 accumulation and mitochondria energy status
evaluation on TFC. A: Immunohistochemical analysis of
TFC exposed to isotype-matched control (400), anti-CD95
(1,000), 2 (1,000), and 20 mM (400) C2-cermide labeled
with GD3 mAb; ultrastructural analysis of mitochondria of
cells treated with isotype-matched control (30,000), anti-
CD95 (30,000), 2 (40,000), and 20 mM (23,000) C2-
cermide. B: Dcm analysis, using JC-1 staining, in cells treated
with IgM, anti-CD95, C2-dihydroceramide (2 and 20 mM), and
C2-ceramide (2 and 20 mM), at 0, 2, and 4 h time points.
C: Immunoblot analysis of cytochrome c on mitochondria and
cytosol of TFC exposed to 2 and 20 mM C2-ceramide. [Color
figure can be viewed in the online issue, which is available at
www.interscience.wiley.com.]
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compared with the low percentage (12.5%
0.4%) of cells with altered Dcm exposed to
dihydroceramide. By contrast, only 20 1.1%
of cells treated with anti-CD95 for 4 h showed
altered Dcm (Fig. 4B).
We investigated the redistribution of cyto-
chrome c from the mitochondrial intermem-
brane space to the cytoplasm. Detecting
cytochrome c by immunoblotting analysis in
isolated mitochondria and cytosol from TFC
cultured with C2-dihydroceramide and C2-cer-
amide (2–20 mM) for 4 h, we found that it was
completely absent in the cytosol of cells treated
with 20 mM C2-ceramide and abundantly pre-
sent in 2 mMC2-ceramide treated cells (Fig. 4C).
Bax and Bak Are Not Oligomerized in TFC
Exposed to High Concentrations of C2-Ceramide
We analyzed the expression levels of Bcl-xl,
Bcl-2, Bak, and Bax by immunoblot in the
mitochondrial and cytoplasmic compartment
of untreated and treated cells with 20 mM C2-
ceramide for 2 h and 4 h. Mitochondria are the
principal site of the action of some of the Bcl-2
family members [Kluck et al., 1997] that are
composed of both anti-apoptotic (Bcl-2, Bcl-xl)
and pro-apoptotic (Bax, Bak) molecules.
In line with Dcm results, we found low Bcl-xl
andBcl-2 expression levels in themitochondrial
and cytoplasmic compartment at both time
points of culture (Fig. 5A). In contrast, Bak
and Bax were scarcely present in mitochondria,
while being abundantly expressed in the cyto-
plasmic compartment (Fig. 5A). These findings
suggest that Bax and Bak are not oligomerized
and inserted into the outer mitochondrial
membrane where they classically elicit their
pro-apoptotic role.
High Levels of C2-Ceramide Are Not Able to
Induce PARP Cleavage and DNA Laddering
Awell-characterized substrate of caspase-3 is
PARP, which maintains the integrity of chro-
mosomal DNA and plays a pivotal role in the
endonucleolytic degradation of DNA. We exam-
ineduntreatedand treated cell lysates forPARP
cleavage products and DNA cleavage into
nucleosome-sized fragments to evaluate cera-
mide effects. As demonstrated in Figure 5B,C
(lane 4), cleavage of PARP and DNA laddering
were not observed in 20 mM C2-ceramide. In
contrast, PARP cleavage and DNA fragmenta-
tion were seen in cells treated with 200 ng/ml of
CH-11 and2mMC2-ceramide (Fig. 5B,C, lane 2).
These results supporta ceramide-induceddeath
mechanism that occurs without leading to
cleavage of nuclear substrates formanifestation
of ceramide effects.
zVAD Failed in the Rescue of TFC From
C2-Ceramide Effects
To determine whether apoptosis induced by
C2-ceramide in TFC required activation of
caspases, we pre-treated cells with the broad
spectrum caspases inhibitor, zVAD-fmk. Ac-
cordingly, when we analyzed 2 h and 4 h C2-
ceramide (2 mM) TFC pretreated with zVAD
(30 mM) for 30 min, no apoptotic feature was
observed (Fig. 5D), while zVAD was not able to
rescue TFC from necrosis when they were
cultured with 20 mM C2-ceramide (Fig. 5D).
These data confirm that TFC necrosis induced
by high levels of C2-ceramide does not require
caspases activation.
DISCUSSION
As shown by several studies, ceramide,
generated by SMase activation, seems to be
involved in cell growth, differentiation, and
apoptosis, essential for the development and
maintenance of tissue homeostasis [Cifone
et al., 1994; Testi, 1996; De Maria et al., 1997].
Our findings focused on the signaling path-
way study following ceramide exposure in
human normal TFC.
The involvement of CD95/CD178 system in
the regulation of thyroid cell apoptosis has been
extensively studied [Borgerson et al., 1999].
Moreover, deregulation of CD95-mediated
apoptosis has been proposed as a possible
common effector of tissue destruction in organ-
specific autoimmune diseases, such as Hashi-
moto’s thyroiditis [Giordano et al., 1997;
Hammond et al., 1997; Stassi et al., 2000, 2001].
Several studies have demonstrated the asso-
ciation of interleukin-1b (IL-1b) with thyroidal
autoimmune diseases [Bendtzen et al., 1989].
IL-1b induces ceramide formation and SM
degradation in porcine thyroid cells [Schneider
et al., 2001].Anatypical proteinkinaseC (PKC),
PKC-x, seems to be the direct target of IL-1band
ceramides action, in response to TNF-a stimula-
tion. The regulation of PKC-x by ceramide
could contribute to NF-kB induction, leading
to cell survival [Muller et al., 1995; Wang et al.,
1999; Schneider et al., 2001]. Therefore, these
data established a new role for ceramide
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in modulating thyroid cell dedifferentiation,
characterized by a SMase-induced thyrocyte
proliferation that was accompanied by the loss
of their ability to iodinate proteins and decrease
the adenylate cyclase system response. More-
over, ceramide is known tobe recruited inCD95,
TNF-a, ionizing radiations, and anticancer
drugs apoptotic-signaling cascade [Ballou
et al., 1996].
Several studies have shown that C2- and C8-
ceramide treatment mimicked the TNF-a-
mediated induction of apoptosis, prevented by
exposure to DAG, PLC, or PMA, thereby
suggesting that PKC activation antagonizes
the SM pathway [Jarvis et al., 1994; Santana
et al., 1996]. In addition, using histochemical
criteria and DNA fragmentation, Jarvis et al.
[1994] have demonstrated that apoptosis is
induced by C2- and C8-ceramide. The effects
of ceramide on DNA fragmentation were inhib-
ited by zinc, suggesting the involvement of a
Ca2þ-dependent endonuclease [Obeid et al.,
1993].
CD95 triggering determines SMase activa-
tion, responsible for SM hydrolysis and result-
ing in ceramide accumulation [Cifone et al.,
1994; Santana et al., 1996]. Then, ceramide is
gradually converted into the apoptotic GD3
ganglioside through the final contribution of a
GD3 synthase (ST8) [De Maria et al., 1997]. We
recently demonstrated that themajority of lym-
phocytes located in closed proximity to CD178þ
Fig. 5. Apoptotic molecule expression and nuclear substrate
evaluation on TFC. A: Immunoblot analysis of anti-apoptotic
molecules (Bcl-xL and Bcl-2) and pro-apoptotic molecules (Bak
and Bax) in the purified mitochondrial and cytoplasmic
compartment from cells untreated and exposed to 20 mM C2-
ceramide for 2 and 4 h. B: Immunoblot detection of cleaved
fragments of PARP on cells treated with isotype-matched
control, anti-CD95, C2-dihydroceramide, and C2-ceramide
(2–20 mM) for 4 h. C: DNA laddering of TFC exposed for 4 h
to 2 mMC2-dihydroceramide (lane 1), 2 mMC2-ceramide (lane 2)
20 mM C2-dihydroceramide (lane 3), and 20 mM C2-ceramide
(lane 4). Lane M represents standard DNA fragments (1 kb).
D: TEM analysis of TFC pre-cultured with 30 mM of zVAD and
subsequently exposed to 2 and 20 mM C2-ceramide.
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thyrocytes, during Hashimoto’s thyroiditis, are
committed to apoptosis, as shown by high levels
of expression of GD3 ganglioside [Stassi et al.,
1999b]. GD3 accumulation seems to be involved
in the ongoing apoptotic process generated by
ceramide [De Maria et al., 1997; Rippo et al.,
2000]. Although ceramide-signaling pathways
have been implicated in cell death, little is
known about the morphological aspects and
nuclear target cleavage in TFC. Toward this
end, we report the biological effects of exogen-
ous ceramide at high concentrations as defined
by morphological criteria, gene apoptotic fac-
tors, PARP cleavage, and DNA laddering.
Our findings show that high levels of cera-
mide (20 mM) exposure determine early mito-
chondrial damage and necrotic features. These
results suggest that the energy status of cells is
altered and unable to support the metabolically
active apoptotic process.
Several studies have demonstrated that cer-
amide induces cell necrosis through disruption
of mitochondrial function and ATP depletion in
rat hepatocytes [Arora et al., 1997; Ha and
Snyder, 1999].
Moreover, studies on MCF-7 breast cancer
cells showed that the apoptotic process can
occur only when sufficient oxygen and energy
supply are available [Formigli et al., 2002].
During ATP depletion, energy levels rapidly
decline [Doctor et al., 1994], and aponecrosis, a
novel type of cell demise sharing the features of
both apoptosis and necrosis, can ensue as the
result of an incomplete execution of the apopto-
tic program [Formigli et al., 2000].
The data presented here suggest that cera-
mide is an additional component of apoptosis
induction in TFC.Moreover, although endogen-
ous ceramide accumulation may promote the
apoptotic process in TFC, exposure to high
levels of synthetic ceramide is likely to result
in necrotic cell death. Therefore, for evaluating
the effects of exogenous ceramide on gene
apoptotic factors, we assessed whether Bax and
Bak, two proapoptotic proteins necessary for
apoptosis in many cell types, are required for
apoptosis induction by triggering cytochrome c
release from TFC mitochondria [Liu et al.,
1996].
In fact, activation and oligomerization of Bax
or Bak have been proposed to result in the
formation ofahomomultimericpore [Saito etal.,
2000; Wei et al., 2001], formation of a voltage-
dependent anion channel-containing pore
[Shimizu et al., 1999] or the permeabilization
ofmitochondrialmembranes [Kluck et al., 1999]
to initiate cytochrome c release. Release of
cytochrome c activates the Apaf-1-caspase-9
apoptosome and downstream effector caspases
[Li et al., 1997], with a progressive mitochon-
drial dysfunction and consequent cell death
[Mootha et al., 2001]. Loss-of-function studies
have revealed that the absence of proapoptotic
Bax and Bak molecules creates a profound
block, preserving mitochondria and inhibiting
apoptosis [Wei et al., 2001], thereby suggesting
that the mitochondrial apoptotic pathway
requires both Bax and Bak oligomerization into
the mitochondrial membranes.
In our model, our findings show that Bax and
Bak are not oligomerized or inserted into the
outer mitochondrial membrane where they
classically elicit their pro-apoptotic role, prov-
ing that high concentrations of exogenous cera-
mide are not able to induce apoptotic cell death
in TFC.
Recently, PARP cleavage has been proposed
to prevent depletion of NAD (a PARP substrate)
and ATP, which are thought to be required for
later events in apoptosis [Herceg and Wang,
1999]. Futhermore, PARP activation has been
shown to prevent induction of necrosis during
apoptosis and ensure appropriate execution of
caspase-mediated programmed cell death,
influencing intracellular ATP levels [Kolesnick
and Fuks, 1995]. Our data show that since
ceramide treatment is not able to determine the
proteolytic cleavage of PARP and the internu-
cleosomal DNA fragmentation, resulting in
depletion ofATP, treated cells undergonecrosis.
This is consistent with the evidence that the
depletion of ATP can transform an ongoing
apoptotic process into necrosis, thereby sug-
gesting that intracellular ATP levels control the
quality of cell death.
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